Bronchiectasis

• EMA approval · 2025-12-04
  EMA Authorised: Brinsupri (Brensocatib monohydrate) — Insmed Netherlands B.V.

  The European Medicines Agency authorized Brinsupri (brensocatib monohydrate) by Insmed Netherlands B.V. for bronchiectasis. This marks EU ap…

• FDA approval · 2025-08-12
  FDA Approved: BRINSUPRI — Original Application (Insmed Incorporated)

  The FDA approved BRINSUPRI (BRENSOCATIB) from Insmed as a new therapy for adults with bronchiectasis to reduce exacerbations. This original …

• FDA approval · 2025-02-12
  FDA Approved: ACETYLCYSTEINE — Original Application (Somerset Therapeutics, LLC)

  FDA approved the original application for acetylcysteine from Somerset Therapeutics, LLC, granting approval for a generic acetylcysteine pro…